Identifying the basic cellular malfunction underlying ALS opens the pathway to developing treatments to prevent the disease by preserving neurons.
St. Jude researchers have found that cells of a deadly acute myeloid leukemia can be killed by blocking production of a molecular “battery.”
Dr. Kalodimos’ appointment will further strengthen basic science programs that serve as the foundation of discovery.
Agreement with Serum Institute of India to develop a vaccine for respiratory syncytial virus, a lower respiratory tract infection in infants and children.
Novel boat-shaped membrane protein provides an architectural solution for PlsC and likely thousands of other enzymes that work within the cell membrane.
Landmark study of the most common pediatric brain tumor reveals new cancer genes and lays the foundation to expand precision medicine.
Researchers offer clues on how mutations in the histone H3 cripple DNA replication and genomic instability, which contribute to development of high-grade glioma.
Researchers have identified a possible genetic marker of influenza severity and evidence it affects the supply of killer T cells that help fight the infection.
Progress reported in identifying childhood cancer patients who are most likely to benefit from fertility preservation measures.
Landmark study of T-lineage acute lymphoblastic leukemia (T-ALL) reveals new mutations and drug development targets.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators in 2016.